Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?
Author:
Funder
Elekta
AstraZeneca
Eli Lilly
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference14 articles.
1. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer;Timmerman;J Clin Oncol,2006
2. Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review;Senthi;Radiother Oncol,2013
3. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors;Chaudhuri;Lung Cancer,2015
4. Subgroup survival analysis in stage I-II NSCLC patients with a central tumor partly treated with risk-adapted SBRT;Stam;Int J Radiat Oncol Biol Phys,2018
5. Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with “Ultracentral” Non-Small Cell Lung Cancer;Tekatli;J Thorac Oncol,2016
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis;Biomarker Research;2024-08-26
2. Dosimetric Analysis of Proximal Bronchial Tree Subsegments to Assess The Risk of Severe Toxicity After Stereotactic Body Radiation Therapy of Ultra-central Lung Tumors;Clinical and Translational Radiation Oncology;2024-03
3. Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT;Clinical and Translational Radiation Oncology;2023-11
4. Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines;Lung Cancer;2023-08
5. Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity;Cancer/Radiothérapie;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3